Weekly Roundup
COVID-19 Vaccine Development, Policy, and Public Perception in the United States
|
|
People, Perceptions, and Poll
|
|
COMMENTARY
What Makes Vaccines Social? Like many social scientists working in the fields of vaccine uptake and disaster response and recovery, we anticipated that widespread acceptance of COVID-19 vaccines would be a critical issue—an issue upon which the success of the vaccination campaign, and the solution to the pandemic, would hinge. That is what we are now seeing today. (Sapiens, 1/15/21)
|
|
GUIDANCE
Public health messaging 101: How to convince the vaccine skeptics. How can health care organizations tailor public health messages that will reach specific population groups in an efficient manner that will actually increase uptake? Brian Castrucci, DrPH, President and CEO of the de Beaumont Foundation and Georges Benjamin, MD, Executive Director of the American Public Health Association, shared a few insights to help health care CEOs create an effective COVID-19 vaccine public health messaging strategy.. (Health Evolution, 1/14/21)
|
|
OPINION
Women Will Bear the Burden of Getting Our Aging Parents Vaccinated. Women in this country are more likely to leave the workforce to care for an elderly parent, and those who do provide care are less likely to be employed in general. And because so much of the Covid-19 vaccine scheduling is being handled online, it also means that it won’t just be women with “elderly” parents taking on this new workload. (Medium, 1/15/21)
|
|
NEWS
What to Know About Vaccine-Linked Deaths, Allergies. Many people who’ve received the first two Western shots deployed, one from Pfizer Inc. and BioNTech SE, and another from Moderna Inc., have experienced fever, headache and pain at the site of the injection. These side effects generally disappear quickly. More worrisome, Norway has reported deaths among elderly people with serious underlying health conditions following administration of the Pfizer-BioNTech vaccine -- possibly linked to those side effects. (Bloomberg, 1/18/21)
|
|
POLL
Americans criticize vaccine rollout as too slow. Most Americans are not satisfied with the coronavirus vaccine distribution in their state, with a majority saying it is going too slowly and feeling that the process of how to go about getting a vaccine hasn't been well-explained yet. This comes as more people are now interested in getting vaccinated, with those most eager to get one more critical of the speed of its rollout. (CBS News, 1/17/21)
See also:
|
|
PODCAST
What Happens When You Get A COVID-19 Vaccine That Uses mRNA. On this week’s episode of PODCAST-19, we talk with Dr. Margaret Liu, one of the pioneers of gene-based vaccines, about vaccines that use mRNA to help us build immunity to COVID-19, including the Pfizer-BioNTech and Moderna vaccines. How is this method different from vaccines in the past, and what does the mRNA do once it gets inside our bodies? (FiveThirtyEight, 1/15/21)
|
|
NEWS
Vaccines Need Not Completely Stop COVID Transmission to Curb the Pandemic. Sterilizing immunity may have been a lofty goal for COVID-19 vaccine manufacturers, though not necessary to curb disease. According to Natasha Crowcroft, senior technical adviser for measles and rubella at the World Health Organization, the very concept of such immunity is nuanced. “In reality, the spectrum of protection might best be framed as the extent to which vaccination prevents transmission of the wild-type virus or bacteria,” she says. (Scientific American, 1/18/21)
|
|
EXECUTIVE ORDER
See also:
|
|
STRATEGY
National Strategy for the COVID-19 Response and Pandemic Preparedness. Full implementation of the National Strategy for COVID-19 will require sustained, coordinated, and complementary efforts of the American people, as well as groups across the country, including State, local, territorial, and Tribal governments; health care providers; businesses; manufacturers critical to the supply chain, communities of color, and unions. (The White House, 1/21/21)
See also:
|
|
NEWS
Some Medical Students Celebrate With Covid Vaccine Selfies as Others Wait in Line. In December, the Centers for Disease Control and Prevention announced guidelines establishing priorities of who should get the vaccines first as the rollout began. Although the guidelines were broad, medical students learned that they could be included among the first wave of health care workers, especially those involved with care of Covid patients. But the rollout has varied widely across the country’s 155 medical schools, which have each set priorities based on the availability of vaccine doses in their state. (New York Times, 1/14/21)
|
|
ANALYSIS
Orchestrating Systems-Level Change in the Battle Against COVID-19. As of today, no group or institution—no corporation, business consortium, government entity, or international agency—can single-handedly design and implement a system to provide the vaccine to all seven billion people on Earth. In the United States, the lack of planning for vaccine delivery may be even more stark: While the United States is mounting the largest vaccination development effort in history, there is a serious lack of strategy for building trust and for distributing the vaccine, especially to the most-marginalized and highest-risk populations. (Stanford Social Innovation Review, 1/13/21)
|
|
NEWS
If They Nail Vaccinations, Drugstores Will Be the Heroes of 2021. U.S. pharmacies gave out about a third of adult flu shots in 2018, up from just 18% in 2012. President Joe Biden’s ambitious $20 billion plan to reboot the troubled vaccine distribution rollout to deliver on his pledge of 100 million shots in 100 days will rely, in part, on drugstores. “We are going to fully activate the pharmacies across the country,” Biden said on Jan. 15. (Bloomberg, 1/21/21)
|
|
This newsletter supports CommuniVax, a research coalition convened by the
Johns Hopkins Center for Health Security and the Texas State University Department of Anthropology,
with support from the Chan Zuckerberg Initiative.
|
|
|
|
|
|
|